The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Quite a bit of glass half empty cynicism in recent posts..which I completely understand. For what it’s worth AC did tell me that after c-37 and c-30 they would drill virgin well zen 1 and then probably drill next to or sidetrack z-21.
The cash burn with a tiny team doing nothing but preparing for the upcoming meeting with the fda is utterly preposterous
600-700bopd would give Bloe a great solid footing to kick on from over the coming months and years but I wouldn’t expect 20p as a regular share price until you prove you can do it again and get to 1,500bopd
When you start producing it’s all about the revenue you’re generating month in month out, the rest of the possible prize in your asset doesn’t come into it until you prove you repeat consistently and get it out of the ground again and again effectively that’s why industry experts use the general rule of thumb of £40m for every 1,000bopd
It is definitely a possibility cliff as there is no doubt that some very murky things still (and always will) happen in business whenever corporate self interest and human beings innate ability to be open to taking back handers collide. Someone could be looking to Phoenix Iclaprim I.e.push motif to insolvency and then take the asset and down the line claim the prize of approval for themselves. A gut wrenching thought for long term holders and one I most definitely hope doesn’t come to pass. Roll on fda meeting and some common sense prevailing!
Gunthorpe I’ve been here over 2 years and currently have a paper loss of just under £150k so believe it or not I’m rather keen to understand what may happen if we finally succeed and looking at a peers performance after a big result gives a strong indicator
Sea I would suggest that BLOE are having a bit of a sp shocker considering the level of result they had yesterday. The is giving me a slight concern/reality check about what we can realistically expect with a great result at c-37
rocklawn the only strong demand is coming from our finance/account team every month telling AC we need to raise more money as another month has passed without getting to our stated objectives and there are different financial balls to be juggled... one thing I know to be true is long termers here genuinely deserve some success
What’s interesting is they’re only up between 60-80% on pretty ground breaking news. If we happened to get 1,000 bopd from c-37 I would be hoping to get a much higher jump than 60-80% . I always remember malcy saying as a rule of thumb every 1,000 bopd should equate to circa £40m on a company’s market cap
Good news but the cash burn is off the scale considering we’re doing no scientific trials...must be eating a lot of hob nobs at head office
Good news ...we’re going to have to be patient until early June to discover what we need to do to move forward towards approval